文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

伊利诺伊州芝加哥COVID-19患者的临床病程及与住院和危重症相关的因素

Clinical Course and Factors Associated With Hospitalization and Critical Illness Among COVID-19 Patients in Chicago, Illinois.
PubMed 文献 · Acad Emerg Med · 2020-08-25
一句话结论回顾性队列显示,呼吸困难(OR=4.53)和既往卒中(OR=3.20)是COVID-19住院的强预测因素,肌钙蛋白升高(OR=3.65)与危重症相关。

该回顾性、基于登记处的队列研究纳入2020年3月4日至6月21日芝加哥拉什大学医学中心8673例COVID-19患者,比较住院与非住院及危重症患者。1483例(17.1%)住院,528例(6.1%)入住ICU。住院风险因素包括高龄、男性(OR=1.69)、西班牙裔/拉丁裔(OR=1.52)、高血压(OR=1.77)、糖尿病(OR=1.84)、既往CVA(OR=3.20)、冠心病(OR=1.45)、心力衰竭(OR=1.79)、慢性肾病(OR=2.60)、终末期肾病(OR=2.22)、肝硬化(OR=2.03)、发热(OR=1.43)和呼吸困难(OR=4.53)。危重症风险因素包括男性(OR=1.45)、充血性心力衰竭(OR=1.45)、阻塞性睡眠呼吸暂停(OR=1.58)、血液系统恶性肿瘤(OR=3.53)、白细胞增多(OR=1.53)、中性粒细胞/淋巴细胞比值升高(OR=1.61)、低白蛋白血症(OR=1.80)、AST升高(OR=1.66)、乳酸升高(OR=1.95)、D-二聚体升高(OR=1.44)和肌钙蛋白升高(OR=3.65)。作者认为临床医生在评估COVID-19患者时应考虑这些因素。

要点

  • 呼吸困难与住院风险独立相关(OR=4.53,95%CI 3.75–5.47),既往CVA次之(OR=3.20,95%CI 1.99–5.14)。
  • 肌钙蛋白升高与危重症风险相关(OR=3.65,95%CI 2.03–6.57),血液系统恶性肿瘤OR=3.53(95%CI 1.26–9.86)。
  • 慢性肾病(OR=2.60,95%CI 1.77–3.83)和终末期肾病(OR=2.22,95%CI 1.12–4.41)与住院风险相关。
  • 代谢与炎症指标异常(乳酸升高OR=1.95、低白蛋白血症OR=1.80、中性粒细胞/淋巴细胞比值升高OR=1.61、白细胞增多OR=1.53、AST升高OR=1.66、D-二聚体升高OR=1.44)与危重症相关。
  • 作者认为临床医生在评估COVID-19患者时应考虑这些因素以指导风险分层。

适用人群与场景

  • 2020年3月4日至6月21日期间就诊于芝加哥拉什大学医学中心的COVID-19患者,共8673例。

诊断标准与关键阈值

  • 住院风险因素包括高龄、男性(OR=1.69,95%CI 1.44–1.98)、西班牙裔/拉丁裔(OR=1.52,95%CI 1.18–1.92)、高血压(OR=1.77,95%CI 1.46–2.16)、糖尿病(OR=1.84,95%CI 1.53–2.22)、既往CVA(OR=3.20,95%CI 1.99–5.14)、冠心病(OR=1.45,95%CI 1.03–2.06)、心力衰竭(OR=1.79,95%CI 1.23–2.61)、慢性肾病(OR=2.60,95%CI 1.77–3.83)、终末期肾病(OR=2.22,95%CI 1.12–4.41)、肝硬化(OR=2.03,95%CI 1.42–2.91)、发热(OR=1.43,95%CI 1.19–1.71)、呼吸困难(OR=4.53,95%CI 3.75–5.47)。
  • 危重症风险因素包括男性(OR=1.45,95%CI 1.12–1.88)、充血性心力衰竭(OR=1.45,95%CI 1.00–2.12)、阻塞性睡眠呼吸暂停(OR=1.58,95%CI 1.07–2.33)、血液系统恶性肿瘤(OR=3.53,95%CI 1.26–9.86)、白细胞增多(OR=1.53,95%CI 1.15–2.17)、中性粒细胞/淋巴细胞比值升高(OR=1.61,95%CI 1.20–2.17)、低白蛋白血症(OR=1.80,95%CI 1.39–2.32)、AST升高(OR=1.66,95%CI 1.20–2.29)、乳酸升高(OR=1.95,95%CI 1.40–2.73)、D-二聚体升高(OR=1.44,95%CI 1.05–1.97)、肌钙蛋白升高(OR=3.65,95%CI 2.03–6.57)。

研究设计与关键结果

  • 回顾性、基于登记处的队列研究,纳入8673例COVID-19患者,1483例(17.1%)住院,528例(6.1%)入住ICU。
  • 住院风险因素包括高龄、男性(OR=1.69,95%CI 1.44–1.98)、西班牙裔/拉丁裔(OR=1.52,95%CI 1.18–1.92)、高血压(OR=1.77,95%CI 1.46–2.16)、糖尿病(OR=1.84,95%CI 1.53–2.22)、既往CVA(OR=3.20,95%CI 1.99–5.14)、冠心病(OR=1.45,95%CI 1.03–2.06)、心力衰竭(OR=1.79,95%CI 1.23–2.61)、慢性肾病(OR=2.60,95%CI 1.77–3.83)、终末期肾病(OR=2.22,95%CI 1.12–4.41)、肝硬化(OR=2.03,95%CI 1.42–2.91)、发热(OR=1.43,95%CI 1.19–1.71)、呼吸困难(OR=4.53,95%CI 3.75–5.47)。
  • 危重症风险因素包括男性(OR=1.45,95%CI 1.12–1.88)、充血性心力衰竭(OR=1.45,95%CI 1.00–2.12)、阻塞性睡眠呼吸暂停(OR=1.58,95%CI 1.07–2.33)、血液系统恶性肿瘤(OR=3.53,95%CI 1.26–9.86)、白细胞增多(OR=1.53,95%CI 1.15–2.17)、中性粒细胞/淋巴细胞比值升高(OR=1.61,95%CI 1.20–2.17)、低白蛋白血症(OR=1.80,95%CI 1.39–2.32)、AST升高(OR=1.66,95%CI 1.20–2.29)、乳酸升高(OR=1.95,95%CI 1.40–2.73)、D-二聚体升高(OR=1.44,95%CI 1.05–1.97)、肌钙蛋白升高(OR=3.65,95%CI 2.03–6.57)。

证据类型、等级与局限

  • 回顾性、基于登记处的队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,临床医生在评估COVID-19患者时应考虑上述与住院和危重症相关的因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: SARS-CoV-2 is a global pandemic associated with significant morbidity and mortality. However, information from United States cohorts is limited. Understanding predictors of admission and critical illness in these patients is essential to guide prevention and risk stratification strategies.

METHODS: This was a retrospective, registry-based cohort study including all patients presenting to Rush University Medical Center in Chicago, Illinois, with COVID-19 from March 4, 2020 to June 21, 2020. Demographic, clinical, laboratory, and treatment data were obtained from the registry and compared between hospitalized and nonhospitalized patients as well as those with critical illness. We used logistic regression modeling to explore risk factors associated with hospitalization and critical illness.

RESULTS: A total of 8,673 COVID-19 patients were included in the study, of whom 1,483 (17.1%) were admitted to the hospital and 528 (6.1%) were admitted to the intensive care unit. Risk factors for hospital admission included advanced age, male sex (odds ratio [OR] = 1.69, 95% confidence interval [CI] = 1.44 to 1.98), Hispanic/Latino ethnicity (OR = 1.52, 95% CI = 1.18 to 1.92), hypertension (OR = 1.77, 95% CI = 1.46 to 2.16), diabetes mellitus (OR = 1.84, 95% CI = 1.53 to 2.22), prior CVA (OR = 3.20, 95% CI = 1.99 to 5.14), coronary artery disease (OR = 1.45, 95% CI = 1.03 to 2.06), heart failure (OR = 1.79, 95% CI = 1.23 to 2.61), chronic kidney disease (OR = 2.60, 95% CI = 1.77 to 3.83), end-stage renal disease (OR = 2.22, 95% CI = 1.12 to 4.41), cirrhosis (OR = 2.03, 95% CI = 1.42 to 2.91), fever (OR = 1.43, 95% CI = 1.19 to 1.71), and dyspnea (OR = 4.53, 95% CI = 3.75 to 5.47). Factors associated with critical illness included male sex (OR = 1.45, 95% CI = 1.12 to 1.88), congestive heart failure (OR = 1.45, 95% CI = 1.00 to 2.12), obstructive sleep apnea (OR = 1.58, 95% CI = 1.07 to 2.33), blood-borne cancer (OR = 3.53, 95% CI = 1.26 to 9.86), leukocytosis (OR = 1.53, 95% CI = 1.15 to 2.17), elevated neutrophil-to-lymphocyte ratio (OR = 1.61, 95% CI = 1.20 to 2.17), hypoalbuminemia (OR = 1.80, 95% CI = 1.39 to 2.32), elevated AST (OR = 1.66, 95% CI = 1.20 to 2.29), elevated lactate (OR = 1.95, 95% CI = 1.40 to 2.73), elevated D-Dimer (OR = 1.44, 95% CI = 1.05 to 1.97), and elevated troponin (OR = 3.65, 95% CI = 2.03 to 6.57).

CONCLUSION: There are a number of factors associated with hospitalization and critical illness. Clinicians should consider these factors when evaluating patients with COVID-19.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Gottlieb M, Sansom S, Frankenberger C, et al. Clinical Course and Factors Associated With Hospitalization and Critical Illness Among COVID-19 Patients in Chicago, Illinois. Acad Emerg Med. 2020. PMID: 32762106. doi:10.1111/acem.14104

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。